Jun Ma
Researcher Next ID · RN-022889
Researcher · Medicine
American Society of Clinical Oncology
Alexandria, Singapore
- Works count
- 1,060
- Citation count
- 44,934
- H-index
- 102
- i10-index
- 589
Research interests
Publications
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)01123-5
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1905287
Nasopharyngeal carcinoma
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30956-0
Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma
Clinical Cancer Research · 2019 · https://doi.org/10.1158/1078-0432.ccr-18-3065
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial
International Journal of Cancer · 2019 · https://doi.org/10.1002/ijc.32099
Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China
Annals of Oncology · 2019 · https://doi.org/10.1093/annonc/mdz231
Proposed modifications and incorporation of plasma Epstein‐Barr virus DNA improve the TNM staging system for Epstein‐Barr virus‐related nasopharyngeal carcinoma
Cancer · 2018 · https://doi.org/10.1002/cncr.31741
Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
BMJ · 2018 · https://doi.org/10.1136/bmj.k4226
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2016.67.4119
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30410-7
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)70126-9
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70102-x
A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy
PLoS ONE · 2012 · https://doi.org/10.1371/journal.pone.0036466
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70320-5
How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?
International Journal of Radiation Oncology*Biology*Physics · 2010 · https://doi.org/10.1016/j.ijrobp.2010.03.024
Re-Evaluation of 6th Edition of AJCC Staging System for Nasopharyngeal Carcinoma and Proposed Improvement Based on Magnetic Resonance Imaging
International Journal of Radiation Oncology*Biology*Physics · 2009 · https://doi.org/10.1016/j.ijrobp.2008.07.062
Current projects
No projects listed.